GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Neovasc Inc (TSX:NVCN) » Definitions » Accumulated other comprehensive income (loss)

Neovasc (TSX:NVCN) Accumulated other comprehensive income (loss) : C$-8.46 Mil (As of Dec. 2022)


View and export this data going back to 2001. Start your Free Trial

What is Neovasc Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Neovasc's Accumulated other comprehensive income (loss) for the quarter that ended in Dec. 2022 was C$-8.46 Mil.

Neovasc's quarterly Accumulated other comprehensive income (loss) declined from Jun. 2022 (C$-7.98 Mil) to Sep. 2022 (C$-8.31 Mil) and declined from Sep. 2022 (C$-8.31 Mil) to Dec. 2022 (C$-8.46 Mil).

Neovasc's annual Accumulated other comprehensive income (loss) declined from Dec. 2020 (C$-9.76 Mil) to Dec. 2021 (C$-10.09 Mil) but then increased from Dec. 2021 (C$-10.09 Mil) to Dec. 2022 (C$-8.46 Mil).

Neovasc Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Neovasc's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neovasc Accumulated other comprehensive income (loss) Chart

Neovasc Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -10.28 -8.09 -9.76 -10.09 -8.46

Neovasc Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.09 -7.89 -7.98 -8.31 -8.46

Neovasc Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Neovasc Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Neovasc's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Neovasc (TSX:NVCN) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Neovasc Inc (TSX:NVCN) » Definitions » Accumulated other comprehensive income (loss)
Comparable Companies
BSGM OSA AXDX SRTS TBIO SONX ELMD XTNT HYPR EAR ABT MDT SYK BSX SZSE:300760 EW DXCM ZBH ALGN PODD
Traded in Other Exchanges
N/A
Address
13562 Maycrest Way, Suite 5138, Richmond, BC, CAN, V6V 2J7
Website
https://www.neovasc.com
Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. The company earns revenue from one source, the Reducer.